PMID: 11906546Mar 22, 2002Paper

A combination of platinum and tamoxifen in advanced ovarian cancer failing platinum-based chemotherapy: results of a Phase II study

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
P Benedetti PaniciS Mancuso

Abstract

The treatment of recurrent or progressive ovarian cancer has limited therapeutic potential. The clinical outcome of second-line therapy largely depends on the potential chemo-sensitivity of the tumor expressed during up-front chemotherapy, as well as on the treatment-free interval from the last course of cytotoxic therapy. However, the identification of agents such as tamoxifen (TAM) at nontoxic doses, able to act synergistically with standard chemotherapy, may be useful to overcome resistance. Fifty patients with recurrent or progressive ovarian cancer following platinum (P)-based chemotherapy (28 platinum-resistant and 22 platinum-sensitive) entered a Phase II trial to evaluate the efficacy and toxicity of P re-challenge with the addition of TAM as a chemotherapy response modulator. The choice of the P compound (100 mg/m2 cisplatin or 400 mg/m2 carboplatin, q3 weeks) was made on the basis of the prior total cisplatin dose and the presence of neurotoxicity. TAM was administered at the doses of 80 mg/day for 30 days followed by 40 mg/day for the remaining period of treatment. Toxicity consisted mainly of mild to moderate nausea and vomiting (76%), peripheral neuropathy (43%), nephrotoxicity (4%), anemia (16%), leukopenia (58%) ...Continue Reading

References

Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G ScambiaS Mancuso
Dec 1, 1992·Gynecologic Oncology·I VergoteC Tropé
Feb 20, 1992·International Journal of Cancer. Journal International Du Cancer·E F McClayR E Bellet
Apr 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M Markman, W Hoskins
Feb 11, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M MarkmanW Hoskins
Mar 11, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M MarkmanJ L Lewis
Sep 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B ReichmanP Saigo
Oct 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J D AhlgrenD Alt
May 3, 1995·Journal of the National Cancer Institute·M J PiccartS Kaye
Dec 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E L TrimbleR Hayn
Sep 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J T ThigpenR J Barrett
Oct 19, 1994·Journal of the National Cancer Institute·B LundJ P Neijt
Dec 2, 1993·International Journal of Cancer. Journal International Du Cancer·E F McClayS B Howell
Sep 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E BajettaC Carnaghi
Mar 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F M MuggiaL J Liang
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R F Ozols
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W ten Bokkel HuininkJ F Heron

❮ Previous
Next ❯

Citations

Sep 16, 2003·Seminars in Oncology Nursing·Alan N Gordon, Julie Butler
Oct 28, 2003·Reproductive Biology and Endocrinology : RB&E·Shuk-Mei Ho
Nov 1, 2006·Women's Health·Maurie Markman
Oct 5, 2010·Women's Health·T S KristedjaM Cristea
Oct 10, 2012·Endocrine-related Cancer·Francesmary ModugnoSteffi Oesterreich
Dec 14, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M A Bookman
Mar 17, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·H ZhengS Fu
Sep 17, 2015·Endocrine-related Cancer·Helen GharwanChristina M Annunziata
Sep 19, 2006·Yi chuan xue bao = Acta genetica Sinica·Zong-Bin LiJian Lu
Oct 2, 2003·British Journal of Cancer·A R ClampUNKNOWN Cancer Research UK Phase I/II Committee
Nov 28, 2017·Current Opinion in Obstetrics & Gynecology·Laura Paleari, Andrea DeCensi
Jun 3, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gordon J S RustinRaymond W Ruddon
Jun 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John F SmythSimon P Langdon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.